Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary L Johnson

Showing results (91-100 of 171) with videos related to

Pageof 18
Sort By:
Oncogene|September 21, 2002
MEKK1-induced apoptosis requires TRAIL death receptor activation and is inhibited by AKT/PKB through inhibition of MEKK1 cleavageAndrea H Bild, Francisco J Mendoza, Erika M Gibson, et al.
NPJ Breast Cancer|April 10, 2021
SOX4 and SMARCA4 cooperatively regulate PI3k signaling through transcriptional activation of TGFBR2Gaurav A Mehta, Steven P Angus, Christen A Khella, et al.
The Journal of Cell Biology|December 18, 2013
Loss of Arp2/3 induces an NF-κB-dependent, nonautonomous effect on chemotactic signalingCongying Wu, Elizabeth M Haynes, Sreeja B Asokan, et al.
European Journal of Immunology|September 30, 2003
MEF2C regulates c-Jun but not TNF-alpha gene expression in stimulated mast cellsXudong Wei, Weiyong Sun, Ruihua Fan, et al.
The Journal of Clinical Investigation|July 18, 2002
The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophyJunichi Sadoshima, Olivier Montagne, Qian Wang, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 31, 2023
Combined kinome inhibition states are predictive of cancer cell line sensitivity to kinase inhibitor combination therapiesChinmaya U Joisa, Kevin A Chen, Samantha Beville, et al.
Metabolites|June 23, 2017
Non-Targeted Metabolomics Analysis of the Effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Heart, Muscle, Liver and Serum Metabolism In VivoBrian C Jensen, Traci L Parry, Wei Huang, et al.
Nature Cell Biology|November 25, 2003
Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shockMark T Uhlik, Amy N Abell, Nancy L Johnson, et al.
Molecular Cancer Therapeutics|August 28, 2020
<i>Nf1</i>-Mutant Tumors Undergo Transcriptome and Kinome Remodeling after Inhibition of either mTOR or MEKDaniela Pucciarelli, Steven P Angus, Benjamin Huang, et al.
Molecular and Cellular Biology|May 30, 2013
SWI/SNF chromatin-remodeling factor Smarcd3/Baf60c controls epithelial-mesenchymal transition by inducing Wnt5a signalingNicole Vincent Jordan, Aleix Prat, Amy N Abell, et al.
Pageof 18

Showing results (91-100 of 171) with videos related to

Sort By:
Pageof 18
Oncogene|September 21, 2002
MEKK1-induced apoptosis requires TRAIL death receptor activation and is inhibited by AKT/PKB through inhibition of MEKK1 cleavageAndrea H Bild, Francisco J Mendoza, Erika M Gibson, et al.
NPJ Breast Cancer|April 10, 2021
SOX4 and SMARCA4 cooperatively regulate PI3k signaling through transcriptional activation of TGFBR2Gaurav A Mehta, Steven P Angus, Christen A Khella, et al.
The Journal of Cell Biology|December 18, 2013
Loss of Arp2/3 induces an NF-κB-dependent, nonautonomous effect on chemotactic signalingCongying Wu, Elizabeth M Haynes, Sreeja B Asokan, et al.
European Journal of Immunology|September 30, 2003
MEF2C regulates c-Jun but not TNF-alpha gene expression in stimulated mast cellsXudong Wei, Weiyong Sun, Ruihua Fan, et al.
The Journal of Clinical Investigation|July 18, 2002
The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophyJunichi Sadoshima, Olivier Montagne, Qian Wang, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 31, 2023
Combined kinome inhibition states are predictive of cancer cell line sensitivity to kinase inhibitor combination therapiesChinmaya U Joisa, Kevin A Chen, Samantha Beville, et al.
Metabolites|June 23, 2017
Non-Targeted Metabolomics Analysis of the Effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Heart, Muscle, Liver and Serum Metabolism In VivoBrian C Jensen, Traci L Parry, Wei Huang, et al.
Nature Cell Biology|November 25, 2003
Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shockMark T Uhlik, Amy N Abell, Nancy L Johnson, et al.
Molecular Cancer Therapeutics|August 28, 2020
<i>Nf1</i>-Mutant Tumors Undergo Transcriptome and Kinome Remodeling after Inhibition of either mTOR or MEKDaniela Pucciarelli, Steven P Angus, Benjamin Huang, et al.
Molecular and Cellular Biology|May 30, 2013
SWI/SNF chromatin-remodeling factor Smarcd3/Baf60c controls epithelial-mesenchymal transition by inducing Wnt5a signalingNicole Vincent Jordan, Aleix Prat, Amy N Abell, et al.
Pageof 18